Amit Gupta Sells 6,676 Shares of Cardlytics (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 6,676 shares of the company’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $4.03, for a total transaction of $26,904.28. Following the sale, the chief executive officer owned 125,389 shares of the company’s stock, valued at $505,317.67. The trade was a 5.06% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Amit Gupta also recently made the following trade(s):

• On Monday, August 17th, Amit Gupta sold 6,785 shares of Cardlytics stock. The stock was sold at an average price of $3.97, for a total value of $26,936.45.
• On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total value of $42,319.60.
• On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total value of $28,526.22.

Cardlytics Stock Up 1.7%

NASDAQ CDLX traded up $0.07 on Tuesday, reaching $4.12. The company had a trading volume of 53,338 shares, compared to its average volume of 93,274. Cardlytics, Inc. has a 52 week low of $3.49 and a 52 week high of $32.80. The stock’s 50 day moving average is $4.37 and its 200-day moving average is $7.04. The stock has a market cap of $23.94 million, a price-to-earnings ratio of -0.22 and a beta of 0.62.

Cardlytics (NASDAQ:CDLX) last issued its earnings results on Wednesday, August 5th. The company reported ($1.50) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.30) by $0.80. The firm had revenue of $36.88 million for the quarter, compared to analysts’ expectations of $37.00 million. Cardlytics had a negative return on equity of 956.56% and a negative net margin of 55.92%. As a group, analysts forecast that Cardlytics, Inc. will post -3.89 EPS for the current year.

Institutional Investors Weigh In On Cardlytics

Hedge funds have recently modified their holdings of the business. Virtu Financial LLC bought a new position in shares of Cardlytics during the 4th quarter valued at about $39,000. Qube Research & Technologies Ltd bought a new stake in Cardlytics during the 3rd quarter worth approximately $55,000. Marshall Wace LLP bought a new stake in Cardlytics during the 2nd quarter worth approximately $59,000. Renaissance Technologies LLC acquired a new stake in Cardlytics during the 4th quarter worth approximately $62,000. Finally, Barclays PLC lifted its stake in Cardlytics by 31,167.6% in the fourth quarter. Barclays PLC now owns 55,969 shares of the company’s stock valued at $64,000 after buying an additional 55,790 shares in the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

Analyst Ratings Changes

CDLX has been the subject of a number of analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Cardlytics in a report on Wednesday, July 8th. Wall Street Zen upgraded shares of Cardlytics from a “sell” rating to a “hold” rating in a report on Saturday, August 8th. Lake Street Capital set a $10.00 price target on shares of Cardlytics in a research report on Friday, May 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Thursday, June 18th. One analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Sell” and a consensus price target of $10.00.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.